J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea · Delayed Price · Currency is KRW 9,430.00
-780.00 (-7.64%)
At close: Sep 3, 2026
J2KBIO Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 55,200 | 50,288 | 51,996 | - | - | - | |
Market Cap Growth | 3.85% | -3.28% | - | - | - | - |
Enterprise Value | 46,336 | 40,072 | 41,858 | - | - | - |
Last Close Price | 9440.00 | 8600.00 | 8842.65 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.49 | 18.82 | - | - | - | - |
PS Ratio | 1.26 | 1.53 | 1.57 | - | - | - |
PB Ratio | 1.51 | 1.49 | 1.66 | - | - | - |
P/TBV Ratio | 1.53 | 1.51 | 1.68 | - | - | - |
P/FCF Ratio | 11.45 | 41.54 | 2224.56 | - | - | - |
P/OCF Ratio | 10.61 | 24.21 | 7.51 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.06 | 1.22 | 1.26 | - | - | - |
EV/EBITDA Ratio | 5.75 | 9.07 | 8.82 | - | - | - |
EV/EBIT Ratio | 7.13 | 13.72 | 11.54 | - | - | - |
EV/FCF Ratio | 9.61 | 33.10 | 1790.83 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.07 | 0.07 | 0.42 | 0.59 |
Debt / EBITDA Ratio | 0.12 | 0.26 | 0.44 | 0.20 | 1.59 | 2.20 |
Debt / FCF Ratio | 0.21 | 0.94 | 89.34 | 0.65 | 3.46 | 4.36 |
Net Debt / Equity Ratio | -0.24 | -0.34 | -0.35 | -0.18 | -0.05 | 0.04 |
Net Debt / EBITDA Ratio | -1.10 | -2.62 | -2.31 | -0.51 | -0.18 | 0.14 |
Net Debt / FCF Ratio | -1.84 | -9.55 | -469.14 | -1.65 | -0.38 | 0.27 |
Asset Turnover | 1.11 | 0.89 | 1.14 | 1.44 | 0.95 | 0.97 |
Inventory Turnover | 6.97 | 6.70 | 7.27 | 6.47 | 5.03 | 7.59 |
Quick Ratio | 3.14 | 5.86 | 6.64 | 2.90 | 2.52 | 2.37 |
Current Ratio | 4.11 | 7.09 | 7.88 | 3.78 | 3.26 | 2.87 |
Return on Equity (ROE) | 16.91% | 8.21% | -6.80% | 33.43% | 20.83% | 20.06% |
Return on Assets (ROA) | 10.24% | 4.93% | 7.82% | 17.69% | 8.60% | 7.97% |
Return on Invested Capital (ROIC) | 20.23% | 12.05% | 20.70% | 38.56% | 22.38% | 19.77% |
Return on Capital Employed (ROCE) | 17.30% | 8.30% | 10.80% | 30.60% | 16.20% | 14.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 10.53% | 5.32% | -3.18% | - | - | - |
FCF Yield | 8.73% | 2.41% | 0.04% | - | - | - |
Payout Ratio | 26.00% | 44.75% | - | 4.96% | - | - |
Buyback Yield / Dilution | -1.86% | -5.39% | -9.62% | -3.97% | -8051.19% | - |